Article: Radient Pharma Enters Into Distribution Agreement to Launch Sales of Onko-Sure™ IVD Cancer Test in Israel.

Radient Pharmaceuticals Corporation (NYSE - AMEX: RPC), a US-based pharmaceutical company, announced through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI), it has entered into a two-year distribution agreement with Tarom Applied Technologies Ltd. for the marketing and sales of its Onko-Sure™ in vitro diagnostic (IVD) cancer test (see also Biomedicine).

Tarom Applied Technologies Ltd. is an established, privately-owned distributor of products in the biomedical sector with more than 20 years of exclusive representation for OEM diagnostic systems and reagents, biotech and research products and veterinary systems. The company is the exclusive ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!